Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ACTRN12626000475347) titled 'A pilot study of Behaviour Activation Therapy combined with ketamine treatment for people with treatment-resistant depression' on April 16.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Primary Sponsor: The University of Sydney
Condition:
Treatment-resistant depression
Treatment-resistant depression
Mental Health - Depression
Intervention:
A co-produced behaviour activation therapy used as an adjunct to ketamine for treatment-resistant depression (BA-KET).
The BA-KET intervention will be administer...